Fishman Jay A LTD Abb Vie Inc. Transaction History

Fishman Jay A LTD

$1.01 Billion
Q3 2024

A detailed history of Fishman Jay A LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Fishman Jay A LTD holds 67,953 shares of ABBV stock, worth $11.9 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

67,953

Previous 68,495 0.79%

Holding current value

$11.9 Million

Previous $11.7 Million 14.22%

% of portfolio

1.33%

Previous 1.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$163.84 - $199.33 $88,801 - $108,036	-542 Reduced 0.79%	67,953 $13.4 Million
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $10.2 Million - $11.9 Million	66,032 Added 2680.96%	68,495 $11.7 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $10.5 Million - $12.2 Million	-67,682 Reduced 96.49%	2,463 $422,000
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $120,664 - $137,485	755 Added 1.09%	70,145 $12.8 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $336,569 - $379,056	-2,446 Reduced 3.4%	69,390 $10.8 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $834,002 - $965,479	-6,243 Reduced 8.0%	71,836 $10.7 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $12.4 Million - $15.4 Million	-93,693 Reduced 54.54%	78,079 $10.5 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $147,502 - $169,870	-1,020 Reduced 0.59%	171,772 $27.4 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $46,333 - $55,566	335 Added 0.19%	172,792 $27.9 Million
Q3 2022 Oct 26, 2022	BUY	$134.21 - $153.93 $191,920 - $220,119	1,430 Added 0.84%	172,457 $23.1 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $233,541 - $296,907	1,697 Added 1.0%	171,027 $26.2 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $733,016 - $909,467	5,554 Added 3.39%	169,330 $27.5 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.42 Million - $3.06 Million	22,510 Added 15.93%	163,776 $22.2 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $5.28 Million - $5.99 Million	49,595 Added 54.1%	141,266 $15.2 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $2.64 Million - $2.94 Million	25,065 Added 37.63%	91,671 $10.3 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $3.3 Million - $3.63 Million	32,240 Added 93.81%	66,606 $7.21 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $2.54 Million - $3.43 Million	31,560 Added 1124.73%	34,366 $3.68 Million
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $493,982 - $579,772	-5,750 Reduced 67.2%	2,806 $245,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $551,862 - $836,691	8,556 New	8,556 $651,000
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $562,129 - $718,532	-8,556 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $3,471 - $4,085	-45 Reduced 0.52%	8,556 $0
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $3,503 - $4,320	45 Added 0.53%	8,601 $792,000
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $46,005 - $61,605	-500 Reduced 5.52%	8,556 $0
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $632,561 - $807,976	9,056	9,056 $0

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.

Account